Respiratory complex I (NADH:ubiquinone oxidoreductase), one of the largest membranebound enzymes in mammalian cells, powers ATP synthesis by using the energy from electron transfer from NADH to ubiquinone-10 to drive protons across the energy-transducing mitochondrial inner membrane. Ubiquinone-10 is extremely hydrophobic, but in complex I the binding site for its redox-active quinone headgroup is ~20 Å above the membrane surface.
/body Introduction
Respiratory complex I (NADH:ubiquinone oxidoreductase) (1) is a major entry point to the electron transport chain of oxidative phosphorylation in mammalian mitochondria. It catalyzes NADH oxidation coupled to ubiquinone reduction, and captures the free energy produced to transport protons (2, 3) across the mitochondrial inner membrane, supporting ATP synthesis and transport processes. Because complex I is essential for regenerating NAD + to sustain the tricarboxylic acid cycle and fatty acid oxidation, and an important contributor to cellular reactive oxygen species production (4), mutations in its subunits and assembly factors cause a wide range of inherited neuromuscular and metabolic diseases (5) .
Mammalian complex I is a large (1 MDa) membrane-bound enzyme of 45 subunits.
Due to advances in single-particle electron cryo-microscopy (cryoEM), knowledge of its structure (6) (7) (8) has surged forward recently, and descriptions of the 14 core subunits, in mammalian (6) (7) (8) , fungal (9) and bacterial (10) enzymes, have laid a new foundation for mechanistic studies. NADH is oxidized by a flavin near the top of the hydrophilic domain of the L-shaped complex. Then, electrons are transferred along a chain of seven iron-sulfur (FeS) clusters to ubiquinone, bound at the interface of the hydrophilic and membrane domains. The membrane domain contains four antiporter-like units, considered to each transport one proton per cycle. They are connected by elements indicative of ion-transport activities, including pbulges, loops in transmembrane helices (TMHs), and a series of buried charged residues, which also connects them to the quinone-binding region. Although molecular simulations have suggested how conformational, protonation, and hydration changes could propagate through the membrane domain to drive proton transfer events (11) , how the energy from quinone reduction is captured and transferred to proton translocation is currently unknown.
Reactions that may initiate the proton-transfer cascade include movement of a conserved aspartate upon quinone reduction (12) , double reduction of Q to Q 2− or its subsequent protonation to QH 2 (13) , and/or quinone binding/quinol dissociation. It has also been suggested that a permenantly-bound quinone shuttles between two positions in the channel, requiring an additional site for the exchangeable substrate to bind (14) .
Here, we focus on ubiquinone binding and reduction by mammalian complex I.
Strikingly, the binding site for the redox-active ubiquinone headgroup is ~20 Å above the membrane interface, and thought to be accessed by a long, narrow channel ( Figure 1 ) that has been identified in all the structures described so far, but not yet confirmed experimentally.
The headgroup binds in a cleft between the 49 kDa and PSST subunits [we use the nomenclature for the bovine enzyme throughout] and both mutational studies in Yarrowia lipolytica (15) and Escherichia coli (16) , and densities observed in structural data from Thermus thermophilus complex I (10) , indicate that it forms hydrogen bonds with H59 49kDa and Y108 49kDa , placing it within 12 Å of the terminal FeS cluster, N2. At the base of the cleft, the predicted channel meets subunit ND1, and runs along its interface with the 49 kDa and PSST subunits before exiting into the membrane; in total, it is long enough to accommodate most of the ~50 Å long isoprenoid tail of ubiquinone-10. Many structurally diverse inhibitors are thought to bind in the channel (17) and it is a hotspot for both pathophysiological mutations (5, 18) and site-directed variants that affect catalysis (19, 20) .
Here, we have used proteoliposomes (PLs) to determine the kinetics of complex I catalysis with a series of ubiquinone substrates of varying isoprenoid tail length, from ubiquinone-1 (Q1) to ubiquinone-10 (Q10). Previous attempts to investigate the effects of quinone tail length used native membranes supplemented with exogenous quinones, following removal of the endogenous Q10 by lyophilization and pentane extraction (21) (22) (23) . However, these studies were compromised because i) the quinone exchange procedures were detrimental to catalysis (the specific activities were 10-fold lower than observed here) and ii) effects on complex I activity were obscured by the catalysis of other enzymes: Lenaz et al. 
Results

Ubiquinone reduction by complex I is rate limiting for catalysis
The CI-AOX (25) . Furthermore, the k cat value for NADH oxidation by the flavin in bovine complex I is >5000 s -1 (26) , more than ten times faster than the maximum rate of NADH:ubiquinone oxidoreduction, so NADH oxidation does not limit catalysis.
The complex I and AOX used here display similar turnover rates in solution assays with ubiquinone-1, typically 250-300 s -1 and 200-250 s -1 , respectively. Thus, to increase the rate of ubiquinol oxidation, PLs were created starting from a molar ratio of 1:25 CI:AOX. The ratio then effectively doubles to 1:46 ± 1.1 (mean value ± S.D. for all samples) because NADH can only access complex I oriented with its active site outwards (77 ± 10% of the total) whereas AOX substrates can access it in both orientations, and because AOX incorporates into PLs more efficiently than complex I (80 ± 15% and 59 ± 11%, respectively).
This high ratio provides a strong expectation for complex I being rate limiting, and thus for the ubiquinone/ol pool being predominantly oxidized during catalysis (24) . To test this added could be reduced by complex I. Addition of protonophore uncouplers such as gramicidin did not increase the rate so they were not included. Finally, to account for variations in enzyme activity between the quinone-specific batch preparations, two further batches containing samples from each different quinone were prepared (see red and blue points in Figure 3) ; the Q1 and Q2 datasets are from quinone-free PLs included in these batches. The Q10 K M dataset was used as the reference and scaling parameters for the other datasets derived by simultaneous non-linear least squares fitting; the scaling parameters were applied uniformly and so affect only V max , not K M .
Dependence of K M and V max on isoprenoid chain length
The K M and V max values for each ubiquinone (from Figure 3 ) are summarized in Figure 4 . Figure 4A shows that V max (or k cat ) is biphasic and averages to 23 ± 2 µmol min -1 mg -1 (380 s -1 ) for Q10, Q8, Q6 and Q4, and 9.3 ± 0.9 µmol min -1 mg -1 (150 s -1 ) for Q2 and Q1. Previous studies, using pentane-extracted mitochondria, also observed the highest NADH:O 2 activities from Q7 to Q10, with Q1 to Q4 only supporting ~30% of the Q10 value (22, 23) . Figure 4B shows that K M displays a bell-shaped curve with the highest value at Q4. We note that the Q10 K M value reported here of 0.48 mM is lower than that of 3.9 mM we measured previously (24) due to i) improvements to the AOX preparation that have increased its specific activity 2-3 fold; ii) improvements to our quinone quantification protocol; iii) the omission of alamethicin. Alamethicin was used previously (24) to open pores in the membrane to allow NADH to access all the complex I, but we have now found that 11.25 µg mL -1 increases the apparent Q10 K M value from 0.5 ± 0.1 to 1.3 ± 0.4 mM. Alamethicin has been reported to sequester membrane-bound fatty acids (32) so may sequester quinones also, and to induce structural changes in the membrane (33) . Finally, Figure 4C shows that the catalytic efficiency or pseudo second order rate constant, k cat /K M , increases markedly for Q8
and Q10. Previously, k cat /K M was reported to exhibit a bell-shaped dependence on substrate hydrophobicity (34) but the earlier study only used quinones with alkyl chains up to 11
carbons long, whereas the same trend is not replicated here using polyisoprenoid ubiquinones with partition coefficients that vary much more.
Analysis of structural data and docking of Q10
In order to investigate how our data correlate with structural features in complex I, we used the Caver software (35) to detect and compare the proposed quinone-binding sites in available structures. Figure S1 shows that the bovine (6), porcine (7), T. thermophilus (10) , and Y. lipolytica (9) structures describe a common channel. The same channel is truncated in the ovine structure (8) by the 49 kDa subunit b1-b2 loop, and similarly constricted in the Y.
lipolytica structure (9) . Variations in the channels may arise from their medium resolutions and/or different enzyme states; both the ovine and Y. lipolytica enzymes were proposed to be in the 'deactive' state (8, 9) that is unable to reduce quinone, whereas the cryoEM data set for the bovine structure (6) was classified into three states and only the structure allocated to the 'active' state used here. The bovine, porcine and T. thermophilus channels are overlaid in Figure 1 , highlighting their similarity.
To better define how quinones bind in the channel, we modeled Q10 into the channel identified in the bovine complex (PDB ID: 5LC5 (6)) and relaxed the system by atomistic molecular dynamics (MD) simulations ( Figure 5A ). Subsequently, by truncating the relaxed Q10 model, we performed further MD simulations for Q8, Q6, Q4, Q2, and Q1 ( Figure 5B ).
Analyses of the Q10-bound structure showed that its channel closely matches the original channel ( Figure S1 ) and, in all cases, the modeled protein structures around the bound quinones remain in similar conformations except that, for Q1 to Q6 and the empty site, the sidechain of F224 ND1 moves into the position of isoprenoid-7 ( Figure S2A) . Notably, the rootmean-square fluctuations (RMSFs) of the bound quinone variants suggest that the long isoprenoid chains of Q8 and Q6, which overlay closely on that of Q10 ( Figure 5B ), are spatially tightly constrained by the channel, whereas the shorter chains of Q4, Q2 and Q1
have much greater conformational freedom ( Figure 5C ). Strikingly, Figure 6 shows how the properties of residues close to the modeled Q10 vary along it ( Figure S3 presents equivalent data for Q8 to Q1). The environment of the headgroup plus isoprenoids 1 to 3, in the cleft between the PSST and 49 kDa subunits, is primarily hydrophobic and uncharged. Conversely, that of isoprenoids 4 to 7 contains many charged residues. In particular, a group of highly conserved arginines ( Figure 5A ) form an channel elbow that produces a ~100° kink in the modeled Q10 between isoprenoids 4 and 5.
Notably, the hydrophobic faces of the Arg guanidiniums form p-stacking interactions with the isoprenoids, while their edges form polar and electrostatic interactions with a set of conserved Glu/Asp residues ( Figure 5A ), consistent with the known behavior of guanidium groups (36) .
In the modeled structures, interactions between the charged residues separate them into two groups ( Figure S2B ), with the group involving residues on ND1 TMH1 showing less positional variation than that involving primarily residues on the ND1 TMH5-6 loop ( Figure   S2C ), noted previously for its flexibility (6) . Finally, for isoprenoids 8 and 9 the expected hydrophobic nature of the ubiquinone-binding channel is re-established.
Discussion Entry and exit of quinone/quinol to and from the channel
In the classical Michaelis-Menten model, k cat encapsulates all the steps that follow formation of the enzyme-substrate complex, so the fact that k cat is constant for Q4 to Q10 (Figure 4A) suggests that product dissociation, which is expected to be chain-length dependent, is not rate limiting. Alternative rate-limiting steps include the electron-proton transfers for quinone reduction, the coupled processes leading to proton translocation, and all the reactions required to complete the catalytic cycle.
For Q2 and Q1, k cat (150 s -1 ) is substantially lower than for Q4 to Q10 (380 s -1 ) ( Figure   4A ) so the rate-limiting step has either slowed or changed identity. Both possibilities indicate that a chain-length dependent step, such as product dissociation, has slowed down.
Furthermore, the pseudo second-order rate constant k cat /K M (where
provides a guide to the rate constant for substrate binding (k on ) since it approximates to it when k cat > k off and reflects how fast the rate increases with increasing concentration, in substrate-limiting conditions. k cat /K M increases substantially with isoprenoid-tail length ( Figure 4C ). Both observations are consistent with rates of binding and dissociation (i.e.
channel transit rates) increasing with isoprenoid chain length, and being limiting only for Q2 and Q1. We propose three explanations. First, the short isoprenoid tails of Q1, Q2 and Q4 do not overlay their respective Q10 isoprenoids ( Figure 5B ) so they are conformationally mobile within the site ( Figure 5C ): their dissociation may be hindered by lack of directionality, due to lack of a guiding anchor extending down the channel. The tail of Q10 extends into the membrane and may guide the entire dissociation process. Second, for the shorter quinones an additional molecule(s) may enter the channel behind the substrate, impeding its dissociation.
Third, the channel entrance is at a similar depth below the membrane interface to the favored position for the ubiquinone-10 headgroup (37), whereas shorter-tail quinones may distribute differently in the membrane, affecting their binding rates. molecule by one step requires only the residues (and water molecules) around the headgroup and the leading isoprenoid to reorganize (at all other positions one isoprenoid simply replaces another), whereas moving a short chain quinone reguires the region behind it to reorganize also. The energy surface for Q10 transit along the channel may therefore be flatter. In this way, the unusually long substrate-binding channel in complex I need not exert a rate limiting effect on catalysis.
Effect of isoprenoid chain length on binding affinity
In classical Michaelis-Menten kinetics, K M is expressed as (k off + k cat )/k on so, for Q4 to Q10, where k cat is constant ( Figure 4A The relative free energy changes that result from moving each quinone species from a low dielectric (membrane) environment into its complex I binding site were evaluated using continuum electrostatics calculations (38) , revealing a linear dependence on isoprenoid number ( Figure S4 ). The trend is consistent with the decreasing K d proposed for Q4 to Q10, but not with the decrease proposed for Q4 to Q1. Intriguingly, the discrepancy can be explained by considering that k off for Q4, Q2 and Q1 may be decreased, as discussed above, by them lacking a guiding chain for dissociation, and by additional substrate molecules blocking their exit. By decreasing k off these factors 'cage' short chain species in the binding site, independently of their intrinsic affinity for it, and decrease K d . Notably, many tightbinding hydrophobic complex I inhibitors match the dimensions of Q1 to Q4 and are considered to occupy the same binding site; density attributed to piericidin A, which resembles Q3, was observed to overlay density attributed to decylubiquinone in crystallographic maps from T. thermophilus complex I (10). Thus, the potent inhibition of these molecules may also partly result from caging effects.
The concept of a highly-charged channel for the hydrophobic isoprenoid chain, as observed for isoprenoids 4 to 7 ( Figures 5 and 6 ), is intrinsically challenging. Charged cavities in proteins tend to fill with water molecules (39) , and indeed, in MD simulations on the structure of T. thermophilus complex I, waters accumulate in the channel, especially in the charged region (11) . If waters are present it may be that i) the channel has become hydrated artificially during the extended handling required for structural work, or ii) during every catalytic cycle the quinone displaces waters, making an entropic contribution to offset the enthalpy loss of breaking charged and polar interactions. In fact, an unfavourable binding enthalpy from the charged region may mitigate the increasing affinity due to binding an increasing number of hydrophobic units within a hydrophobic channel, and be important for efficient product release. Higher resolution structural data is required for further understanding of this intriguing structural feature.
Finally, increased contributions to the binding affinity from the second, non-polar region at isoprenoids 8 and 9 causes a marked increase in k cat /K M ( Figure 4C ). Because k cat is constant from Q4 to Q10, k cat /K M is dominated by the reciprocal of K M and the apparent discontinuity in Figure 4C results simply from a point of inflexion in the K M curve.
How is proton translocation coupled to quinone reduction?
The identity of the coupling point, at which the redox reaction initiates proton translocation, is currently the most important unknown feature of the complex I mechanism. Molecular dynamics simulations of the movement of D160 49kDa away from H59 49kDa , as a result of proton transfer from H59 to the nascent quinol, have been used to illustrate one possibility (12) . Alternatively, could conformational changes triggered by quinone/quinol moving along the channel, particularly through the charged section, trigger proton translocation? If so, short chain quinones must activate the mechanism as effectively as long chain quinones, since they elicit the same proton-pumping stoichiometry (2, 3). As Figure 5A shows, the charged residues surrounding the channel are, like D160, connected to the center of the membrane domain by a chain of acidic residues (6-10, 12) suggesting how quinone/ol binding/dissociation may be communicated to the proton translocation machinery. To elucidate, challenge and add to proposals for the mechanistic coupling point in complex I requires higher resolution structures set in different states, alongside mutational, functional and computational studies to provide complementary strategies and perspectives on tackling this difficult problem.
Experimental methods
Preparation of AOX
The construct described previously for over-expression of AOX from T. brucei brucei (40) was modified by removing the N-terminal mitochondrial targeting peptide (residues 1-24) and replacing the 6xHis tag with a Twin-Strep® tag (IBA GmbH) (41) . The modified AOX was over-expressed in E. coli strain FN102 (40) in a 60 L fermenter as described previously (24, 40) , except using 100 µg mL 
Preparation of complex I
Mitochondrial membranes were prepared from Bos taurus (bovine) heart (42) then complex I prepared as described previously (24) 
Preparation of CI-AOX PLs
Chloroform solutions (25 mg mL -1 ) of bovine heart phosphatidylcholine (PC), phosphatidylethanolamine (PE) and cardiolipin (CL) were from Avanti Polar Lipids.
Chloroform stock solutions of Q10 (Sigma Aldrich), Q8 (Avanti Polar Lipids), Q6 (Avanti Polar Lipids) and Q4 (Santa Cruz Biotechnology) were created at 2-4 mM. PLs were prepared as described previously (24), starting from mixtures of 8 mg PC, 1 mg PE, 1 mg CL and quinone (as required).
Characterization of PLs
To quanitify the quinone present, 90 µL of ethanol (HPLC grade Chromasolv, Sigma Aldrich) was added to 10 µL of PL solution, sonicated (1 min.) and centrifuged (16,300 x g, 10 min.).
50 µL of supernatant were injected onto a Nucleosil 100-5C18 (Hichrom) column, and run at 30 °C at 800 µL min -1 on an Agilent 1100 series HPLC in 70% ethanol, 30% methanol, 0.07% HClO 4 and 50 mM NaClO 4 for Q10 and Q8, or in 100% methanol, 0.07% HClO 4 and 50 mM NaClO 4 for Q6 and Q4 (retention times 9, 6, 10 and 5 min., respectively).
Concentrations were determined by comparison with known standards. Total phospholipid content was determined as detailed previously (24) . Total protein contents were quantified by the amido black assay, which is insensitive to detergents and high phospholipid concentrations (43) . The NADH:APAD + oxidoreduction assay was used to determine the total complex I content and orientation together with 15 µg mL -1 alamethicin to allow NADH into the PL lumen (24) . The AOX content was taken as the difference between the total protein and complex I contents.
Catalytic activity assays
Activity assays were at 32 °C in 10 mM Tris-SO 4 (pH 7.5 at 32 °C), 50 mM KCl, 200 µM NADH with ~1.5 mg protein mL -1 PLs (24). NADH oxidation was monitored at 340-380 nm (e = 4.81 mM -1 cm -1 ) on a Molecular Devices Spectramax 384 plus platereader. Q2 and Q1
(Sigma Aldrich) were added in ethanol. Inhibitor-insensitive rates were determined in 0.5 µM piericidin A as 0.30 ± 0.03 µmol NADH min -1 mg CI -1 for all quinones except Q1 (which exhibited a concentration-dependent inhibitor-insensitive rate) and have been subtracted from the data reported.
Molecular modeling of ubiquinone-bound structures
Ubiquinone-10 was docked into a channel identified by the HOLE software (44) isoprenoid unit -1 ). Values are from the data in Figure 3 and also given in Table S1 . 
